Drug price increases in the U.S. in 2022
Last Modified: 04-Jan-2022 6:29 AM - 442Number of drugs whose prices have been increased by an average of 5.2% since 30 Dec 2021 and as of 02 Jan 2022. Price increases are based on the list price, which is the official drug price set by the manufacturer. Every year, manufacturers tend to raise the prices of their medications in January and July. Last January, 832 drugs increased in price by an average of 4.6%.
- 434Number of brand drugs whose prices have been increased by an average of 5.2%.
- 8Number of generic drugs whose prices have been increased by an average of 4.2%.
- 13Number of drugs whose price have been increased by 10% or more.
- 16.80%Increase in the price of Solu-Cortef which is manufactured by Pfizer Inc.
- 15.8%Increase in the price of Tyblume which is manufactured by Exeltis USA, Inc.
- 15%Increase in the price of Matulane which is manufactured by Leadiant Biosciences, Inc.
- 15%Increase in the price of Nucynta and Nucynta Er both manufactured by Collegium Pharmaceutical, Inc.
- 10%Increase in the price of Neoprofen which is manufactured by Recordati Rare Diseases.
- 10%Increase in the price of Bicillin Cr, Bicillin Cr 900/300 and Bicillin L-A manufactured by Pfizer Inc.
- 10%Increase in the price of Depo-Estradiol which is manufactured by Pfizer Inc.
- 10%Increase in the price of Fragmin which is manufactured by Pfizer Inc.
- 10%Increase in the price of Camptosar which is manufactured by Pfizer Inc.
- 10%Increase in the price of Paclitaxel.